What Researchers Did
A systematic review was conducted to assess the clinical effectiveness and safety of pharmacological therapies for postradiation pelvic pain.
What They Found
After screening 1514 abstracts, four randomised controlled trials enrolling 355 patients were identified. A single study reported significant pain reduction after 6 months for bladder pain syndrome treated with hyaluronic acid or hyperbaric oxygen, and 4% formalin reduced anorectal pain.
What This Means for Canadian Patients
Canadian patients experiencing postradiation pelvic pain may find some relief with specific pharmacological treatments, though evidence is limited. Discussions with healthcare providers about hyaluronic acid, hyperbaric oxygen, or 4% formalin for bladder or anorectal pain could be beneficial.
Canadian Relevance
This systematic review provides valuable insights for Canadian clinicians managing patients with postradiation pelvic pain, a known complication of cancer treatment.
Study Limitations
The review was limited by the small number of identified studies, their heterogeneity, and poor adverse event reporting, precluding a meta-analysis.